Utility of real-time antifungal susceptibility testing for fluconazole in the treatment of candidemia
- 31 October 2004
- journal article
- research article
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 50 (2), 119-124
- https://doi.org/10.1016/j.diagmicrobio.2004.06.004
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Candidemia in a Tertiary Care Cancer CenterMedicine, 2003
- Antifungal Susceptibility Testing in Teaching HospitalsAnnals of Pharmacotherapy, 2003
- Real-time antifungal susceptibility screening aids management of invasive yeast infections in immunocompromised patients.Journal of Antimicrobial Chemotherapy, 2002
- Trends in Antifungal Susceptibility among Swedish Candida Species Bloodstream Isolates from 1994 to 1998: Comparison of the E-test and the Sensititre YeastOne Colorimetric Antifungal Panel with the NCCLS M27-A Reference MethodJournal of Clinical Microbiology, 2001
- Trends in frequency and susceptibilities of Candida glabrata bloodstream isolates at a university hospitalDiagnostic Microbiology and Infectious Disease, 2001
- Clinical Correlates of Antifungal Macrodilution Susceptibility Test Results for Non-AIDS Patients with Severe Candida Infections Treated with FluconazoleAntimicrobial Agents and Chemotherapy, 2000
- Antifungal susceptibility of 262 bloodstream yeast isolates from a mixed cancer and non-cancer patient population: is there a correlation between in-vitro resistance to fluconazole and the outcome of fungemia?Journal of Infection and Chemotherapy, 2000
- The Epidemiology of Candidemia in Two United States Cities: Results of a Population-Based Active SurveillanceClinical Infectious Diseases, 1999
- The Epidemiology of Hematogenous Candidiasis Caused by Different Candida SpeciesClinical Infectious Diseases, 1997
- The changing face of candidemia: emergence of non-Candida albicans species and antifungal resistanceAmerican Journal Of Medicine, 1996